The names on this page are hidden. Create a free account to reveal 5 records a month, or get Private Equity Intelligence at $249 a month for every name. Every figure, date and source on this page is public either way.

Transactions / C••••••••• E•••••• P•••••••

G•••• C•••••• Recapitalizes C••••••••• E•••••• P•••••••

Majority recapitalizationclosedannounced Feb 20, 2018closed Feb 20, 2018Fact
What happened
Platform
not an add-on on record
Control
Control
Share acquired
unknown
Industry
unknown
Target location
unknown
Seller kind
unknown
Rollover
unknown
Values, only where disclosed
Enterprise value
Not disclosed
Purchase price
Not disclosed
Equity value
Not disclosed
Target revenue
Not disclosed
Target EBITDA
Not disclosed
Multiple
Not disclosed
Parties and roles
5 named
Buy side
  • These Practices have delivered impressive growth and a highly satisfied patient base in the Nevada market, and we are delighted that they have chosen G•••• as their partner for the next chapter of expansion at CompEye,” said W•••••• B•••••, Partner at G••••.
  • D••••• G•••••, Senior Vice President at G••••, said, “We are very pleased to partner with the leadership team and physician shareholders at CompEye to support their continued growth and success.
  • G•••• C•••••• LLC (“G••••”) announced today that it has completed a majority recapitalization of C••••••••• E•••••• P••••••• (“CompEye” or the “Company”), one of the largest vision care management services organizations (“MSO”) in the United States. | published on G•••• C••••••'s own news page gauge
Advisory side
  • B•••••••• C•••••• A•••••••Financial adviserconfirmed
    B•••••••• C•••••• A••••••• acted as the exclusive financial advisor to CompEye.
Side not stated
  • G•••• C•••••• LLC (“G••••”) announced today that it has completed a majority recapitalization of C••••••••• E•••••• P••••••• (“CompEye” or the “Company”), one of the largest vision care management services organizations (“MSO”) in the United States.
Evidence
G•••• C•••••• LLC (“G••••”) announced today that it has completed a majority recapitalization of C••••••••• E•••••• P••••••• (“CompEye” or the “Company”), one of the largest vision care management services organizations (“MSO”) in the United States.